Transcatheter Aortic Valve Replacement (TAVR)

​​​​​​​​​​​​​​​​University of Washington Medical Center Regional Heart Center (RHC) was selected as one of the very first sites in the U.S. to perform TAVR in the landmark PARTNER clinical trial. Since then, RHC has performed over 600 TAVR procedures, averaging 25 cases per month, while the majority of other TAVR centers nationwide perform only a few procedures monthly. We are the most experienced team in Washington, Wyoming, Alaska, Montana, Idaho, and Oregon (WWAMI-OR), with excellent patient and program outcomes, and we continue to participate in clinical trials including PARTNER II and Sapien III.

Our multidisciplinary Heart Team includes cardiac surgeons, interventional cardiologists, cardiac anesthesiologists, cardiac imaging specialists, nurse practitioners, physician assistants, and nurses/technicians with advanced training and experience in the evaluation and treatment of patients for TAVR.

Our extended Heart Team also includes a world-class advanced heart failure service and a 24-hour, on-site cardiothoracic intensive care unit service comprised of cardiac anesthesiologists/intensivists. Full-service patient care is made complete with our colleagues in social work, nutrition, respiratory therapy, physical/occupational/speech therapy and other specialties such as vascular surgery, neurology, and nephrology.

As a referring provider entrusting your patients’ care to us, you can be confident that the experience of our Heart Team and the level of care provided at UWMC is unmatched by any other heart program in the WWAMI-OR region. It is a privilege to collaborate in the care of your patients, and our goal is to return their care to you and their local health care community after a successful TAVR.

Indications for TAVR

  • Patients with symptomatic severe aortic stenosis who are at high risk or prohibitive risk for open heart surgery may undergo TAVR as an FDA-approved procedure.
  • Patients with symptomatic severe aortic stenosis who are at moderate operative risk may participate in the PARTNER II clinical trial, comparing TAVR to surgical valve replacement.
  • Patients who are at prohibitive risk for surgery with a degenerated bioprosthetic aortic valve may be considered in a registry for a TAVR “valve-in-valve” procedure.
  • For the most current information about inclusion/exclusion criteria and arms of the PARTNER research trial, please go to Clinical Trials.gov.
  • For references about TAVR and the PARTNER trial, please ​​​ ​download this list of articles and other publications​.
​ ​

Evaluation for TAVR

Studies Performed by the Primary Cardiologist and Care Team

Most of the studies listed below are performed by the primary cardiologist as part of their evaluation for symptomatic severe aortic stenosis. As appropriate, performing these studies prior to their consultation at UWMC allows our team to provide the most complete evaluation and most expedient treatment recommendation. We are also able to perform any of these studies at UWMC:
  • Transthoracic echocardiogram
  • Cardiac catheterization
  • Pulmonary function testing with DLCO
  • Carotid artery ultrasound
Consultation with RHC Multi-Disciplinary Heart Team

The multi-disciplinary team aims to complete the TAVR evaluation over the course of two visits at UWMC. If a patient is recommended for TAVR, a pre-operative appointment is then scheduled for the following:
  • Cardiac surgery consultation
  • Interventional cardiology consultation
  • TAVR-specific CT angiography of the chest, abdomen, and pelvis
Multi-Disciplinary Team Heart Team Recommendation

Our multi-disciplinary team meets weekly to review each patient’s case in detail and determine the recommended treatment plan. If TAVR is deemed appropriate, the patient is scheduled for a pre-operative assessment and the procedure. If additional specialty tests are requested (e.g., transesophageal echocardiography and dobutamine stress echocardiography), or if other evaluation or treatment is recommended, this will be communicated to the referring provider.

Where is the clinic located and who are the providers?

The clinic is located at the Regional Heart Center on the main floor of University of Washington Medical Center. The address is 1959 N.E. Pacific St., Seattle, WA 98195.

Cardiac Surgery
Interventional Cardiology

How do I refer my patient or contact the TAVR providers?

To refer a patient, complete and return the TAVR referral form.

​The patient care coordinator can be reached at 206.598.8258; fax to 206.598.3037. The providers listed above may be reached by calling UW Medicine Medcon at 1.800.326.5300. If you have any other questions or need further information, you may also contact the Physician Liaison, Laura Matheson, at 206.598.3473 or mathla@uw.edu. ​